| [1] |
YANG Yi, DUO Hong, YANG Ya’nan, LIU Yun, LIANG Fengyi, YANG Xueqin.
The value of tumor marker-based RECIST criteria in efficacy evaluation for advanced ovarian cancer
[J]. Tianjin Medical Journal, 2026, 54(1): 46-51.
|
| [2] |
HUANG Wei, WANG Jianjian, HUANG Ying, YANG Jun.
The effect of compound Kushen Injection combined with chemotherapy and bevacizumab on short-term efficacy of patients with ovarian cancer
[J]. Tianjin Medical Journal, 2026, 54(1): 88-92.
|
| [3] |
LYU Lifeng, GAO Yake, WANG Li.
Prognostic predictive value of peripheral blood T lymphocyte levels and pathological parameters in patients with epithelial ovarian cancer
[J]. Tianjin Medical Journal, 2025, 53(5): 488-491.
|
| [4] |
WANG Aihua, ZHANG Feizhong, WANG Hongying.
Impacts of muscone on malignant progression of ovarian cancer cells by regulating SHH mediated autophagy
[J]. Tianjin Medical Journal, 2024, 52(2): 142-147.
|
| [5] |
YU Ping, ZHOU Min, SU Dan.
Construction and validation of chemotherapy resistance prediction model for ovarian cancer
[J]. Tianjin Medical Journal, 2024, 52(11): 1177-1182.
|
| [6] |
LI Shaoru, LI Yan, LIU Shan, HU Ruili.
Influences of lncRNA SNHG11 on proliferation, apoptosis, migration and invasion of ovarian cancer cells by regulating miR-184/CARM1 signaling axis
[J]. Tianjin Medical Journal, 2023, 51(6): 561-567.
|
| [7] |
LI Juan, NI Huihua.
Relationship between the expression of GPR120 and GPR40 and clinicopathological features and survival outcome of ovarian cancer patients
[J]. Tianjin Medical Journal, 2023, 51(5): 522-526.
|
| [8] |
CHEN Xiao, WU Xiaoying, AN Ming.
Effects of lncRNA SOX21-AS1 expression on proliferation and metastasis of ovarian cancer cells and its mechanism
[J]. Tianjin Medical Journal, 2022, 50(12): 1254-1258.
|
| [9] |
LI Li, GUO Xiang-cui, WANG Qian-qing, LI Jun, GAO Zhi-hui.
Effects of radix hedysari polysaccharide on apoptosis, growth and motility of ovarian cancer SKOV3 cells#br#
[J]. Tianjin Medical Journal, 2021, 49(5): 455-459.
|
| [10] |
LIU Jin-fang, XU Xiao-yan, ZHOU Ru-kui, XU Hui-chao, GAO Yan, MIAO Yu-chuan△.
Effects and mechanism of down-regulated TMEM97 on proliferation and apoptosis of #br#
ovarian cancer SKOV3 cells#br#
[J]. Tianjin Medical Journal, 2020, 48(8): 695-699.
|
| [11] |
CHEN Guo-qing, YE Ping, XU Ling, XIE Xiao-ying△.
Effects of mitophagy mediated by BNIP3 on invasion and metastasis of ovarian cancer HO-8910PM cells under hypoxia#br#
[J]. Tianjin Medical Journal, 2020, 48(8): 700-704.
|
| [12] |
HAN Jian-qiu, HAO Li-hui, XING Ya-ling, ZHANG Yan, WU Wei-guang△.
Long noncoding RNA HOST2 regulates the sensitivity of human ovarian carcinoma SKOV3
cells to cisplatin through PI3K/Akt pathway
[J]. Tianjin Medical Journal, 2020, 48(6): 512-516.
|
| [13] |
CHEN Yan, NIU Xiu-long, YU Chun-yan, LI Yan, DENG Wei-min.
The mechanisms of IL-17A promoting the cisplatin-based drug resistance of ovarian cancer in vivo
[J]. Tianjin Medical Journal, 2020, 48(3): 187-190.
|
| [14] |
QIN Jie, CHAI Xiao-fei, LI Xiang-long.
Study on the mechanism of pabitastat inhibiting the epithelial-mesenchymal transition and growth in ovarian cancer xenografts of nude mice
[J]. Tianjin Medical Journal, 2020, 48(11): 1050-1054.
|
| [15] |
LIN Shi-xin, GAO Jun△.
Progress in the effect of flavonoids on drug resistance in ovarian cancer
[J]. Tianjin Medical Journal, 2020, 48(10): 1010-1014.
|